Clario
Who owns Clario?
Clario is an American HealthTech company, now owned by Thermo Fisher Scientific, which acquired it in 2026 from Novo Holdings, Nordic Capital and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
- ·Fully exited in 2026 to Thermo Fisher Scientific.
- ·Average hold across 5 realized cycles: 9 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
Novo Holdings sold Clario to Thermo Fisher Scientific in 2026 after 10 years.
Astorg sold Clario to Thermo Fisher Scientific in 2026 after 10 years.
Cinven sold Clario to Thermo Fisher Scientific in 2026 after 10 years.
Nordic Capital sold Clario to Thermo Fisher Scientific in 2026 after 10 years.
Omnes Capital sold Clario to Thermo Fisher Scientific in 2026 after 6 years.
More from Cinven Sixth Fund
Other portfolio companies in the same fund.
US· 2019
Denmark· 2019
UK· 2018UK· 2018
Spain· 2018UK· 2018More PE-backed in HealthTech
Comparable healthtech deals from other GPs.
Questions
Who owns Clario?
Clario is now owned by Thermo Fisher Scientific, which acquired it in 2026 from Novo Holdings, Nordic Capital and 3 other investors.
When did Thermo Fisher Scientific acquire Clario?
Thermo Fisher Scientific acquired Clario in 2026, buying from Novo Holdings, Nordic Capital and 3 other investors.
Who did Clario sell to?
Novo Holdings, Nordic Capital and 3 other investors sold Clario to Thermo Fisher Scientific in 2026 (Trade Sale).
Who has owned Clario over time?
Clario has been through 5 private-equity ownership periods: Novo Holdings · via Novo Holdings Growth Investments · 2016–2026 · sold to Thermo Fisher Scientific · (Trade Sale); Nordic Capital · via Nordic Capital Fund VIII · 2016–2026 · sold to Thermo Fisher Scientific · (Trade Sale); Cinven · via Cinven Sixth Fund · 2016–2026 · sold to Thermo Fisher Scientific · (Trade Sale); Astorg · via Astorg VI · 2016–2026 · sold to Thermo Fisher Scientific · (Trade Sale); Omnes Capital · via Omnes Co-Investment · 2020–2026 · sold to Thermo Fisher Scientific · (Trade Sale).